Professor Phillip Stricker

St. Vincent’s Sydney, AUS

As one of the leading experts in the treatment of prostate cancer in Australia, Professor Stricker is the Chairman of the Department of Urology at St. Vincent’s Campus, the Director of the St. Vincent’s Prostate Cancer Centre, Clinical Director of the Australian Prostate Cancer Research Centre – NSW and was an inaugural Director of the Prostate Cancer Foundation of Australia. He was the first Urologist in Australia to exclusively specialize in the treatment of prostate cancer. On Australia Day 2015 Honours list, he was awarded the country’s second highest award, the Officer of the Order of Australia (AO) for “Distinguished service to medicine and medical research, as a leading urologist, a robotic surgery pioneer, a teacher and mentor, and as an advocate for prostate cancer awareness.”

Being the first to perform green laser surgery in Australia, he has an impressive history of clinical research treating Benign Prosatic Hypertrophy with all medications in addition to laser surgery, urolift treatment, and TURP.

His current focus of practice and research is on the quality of life in patients after treatments, improving surgical techniques in prostate surgery, while using and educating physicians to new treatments that are less invasive and result in less side effects for patients.

Professor Stricker has performed 500+ IRE procedures.

Dr. Amit Patel

Duly Health and Care

Dr. Amit Patel is Chairman of Urology at Duly Health and Care, located in the western suburbs of Chicago, Illinois. He studied biochemical engineering at Boston University and completed his medical school training at The Ohio State University. His training for Urology residency and Urologic Oncology fellowship was completed at the Cleveland Clinic and the University of Chicago, respectively. His interests include urologic oncology, including kidney cancer, bladder cancer, and prostate cancer.

His primary focus is to reduce patient morbidity and improve the quality of life for cancer patients through innovative clinical technology and approaches. Dr. Patel is an investigator in multiple urologic oncology clinical trials at Duly Health and Care.

Duly Health and Care has performed 50+ IRE procedures.

Dr. Ranko Miocinovic

Duly Health and Care

Dr. Ranko Miocinovic is a board-certified urologist who completed medical school and urology residency at the University of Toledo Medical Center in Ohio. He underwent further training at the Cleveland Clinic and completed urologic oncology and minimally invasive surgery fellowships in 2012. Dr. Miocinovic is presently employed by a multi-specialty private group in the western suburbs of Chicago, Duly Health and Care. His focus is on care of patients with prostate cancer (MRI-based diagnosis, robotic prostatectomy, advanced prostate cancer, and most recently focal prostate ablation), bladder cancer (robotic cystectomy with intracorporeal ileal conduit and neobladder), and kidney cancer (robotic partial nephrectomy). Dr. Miocinovic also continues to be heavily involved in research and leads multiple clinical trials at his institution, including the PRESERVE study on focal prostate ablation with IRE.

Duly Health and Care has performed 50+ IRE procedures.